Connections with friends, family and other Alzheimer’s caregivers can help

Connections with friends, family and other Alzheimer’s caregivers can help

http://www.tulsaworld.com/article.aspx/Alzheimers_is_part_of_a_couples_love_story/20130811_43_D1_CUTLIN543853

Some caregivers may lose patience with being asked the same question 10 times because their loved one with Alzheimer’s can’t remember the answer. In addition to maintaining friendships and good family relationships, staying connected with other caregivers can help caregivers stay strong and patient.
Read the article >>
Join ALZConnected® >>

Originally, she wasn’t going to download a photo of herself to her page on the popular dating website. If men genuinely wanted to get to know her, based on her profile, she reckoned a picture didn’t matter.
Eventually, she relented and posted a photo – a beautiful one, which John printed off in 2006, two and a half years after searching. He kept that print-off, with her name scribbled in red ink at the top of the page. John fished it from a drawer in the bedroom and showed it to us.
“It was a godsend,” John said.
They were married by 2007.
“We agreed to be bound in sickness and in health,” John said. “After all, that’s life, and we are committed for life, here and forever.”
By 2008, the Broken Arrow newlyweds’ vows would become more meaningful.
“I’d notice occasionally she’d repeat herself,” John said. “I was just chalking it up to stress.”
Lois is in the early stages of Alzheimer’s, signs for which may include some memory loss, impaired ability to learn new information and small personality changes, among others.
John is Lois’ primary caregiver – one of an estimated 214,000 unpaid caregivers in Oklahoma in 2012, according to 2012 figures from the Oklahoma chapter of the Alzheimer’s Association.
The association provides family care consultations, art programs, a teen camp for young caregivers, educational seminars and conferences, and – a boon for John – support groups.
“Everyone who has a relationship with a person with dementia needs to contact the association,” John said. “The help in support and resources is beyond belief.
“And it’s free,” he added. “I would not be as open or as able to handle the anticipatory grief of losing my soulmate gift from God without knowing the Lord and having the Alzheimer’s Association as a resource.”
According to the association’s 2013 Alzheimer’s Disease Facts and Figures, more than 60 percent of Alzheimer’s and dementia caregivers rate the emotional stress of care-giving as high or very high; more than one-third report symptoms of depression. Due to the physical and emotional toll of care-giving, Alzheimer’s and dementia caregivers had $9.1 billion in additional health-care costs of their own in 2012.
“Caregiving takes a toll on a caregiver both physically and emotionally,” explained Ronda Roberts, programs manager for the association’s Oklahoma chapter. “Often they grieve the loss of their companion, friend or partner.
Folks in rural communities and those with limited finances don’t have access to many programs that would ease their load caring for their loved one, Roberts said.
“Caregivers have normal day-to-day responsibilities just like the rest of us,” she continued. “They work, pay the bills, go grocery shopping, take care of their children” – all in combination with the responsibility of physically taking care of another adult.
“They tie their shoes, brush their teeth, make sure they eat, anything they need,” Roberts said.

Midstage nuances

Ames Righter can shower, shave and brush his teeth, but his wife, Jean, has to be right there with him.
Most mornings, she’s out of bed between 5 and 5:30, while Ames sleeps until 8 a.m. It’s her alone time, during which she’ll usually take a stroll, often with Willie, the Righters’ Bichon-toy poodle mix.
Then, it’s back home to feed the animals and make breakfast for herself and Ames.
“It’s very mundane,” she said with a laugh.
Ames is in a more advanced stage of Alzheimer’s than Lois – “midstage,” Jean said, having noticed Ames putting words in wrong places in his sentences. Three years ago, six after they had married, Ames was diagnosed with Alzheimer’s.
“He’s a very articulate, intelligent man, well-read,” Jean told us while Ames played solitaire on the computer. “He’s very outgoing, loves to talk, loves to be with people.”
The day we spoke to Jean, word came that a family member had died.
“Even today, in the sad state he’s in, he would say, ‘Who’s coming to visit today?’ or ‘Who’s coming to dinner?’ “
As time passes, Jean has realized she’s a stronger person than she thought with more patience than she knew she had.
“I’m OK now,” she said she’s told herself in the past few months. “It took a while to get here, and there are a lot of stages a person goes through – anger, some frustration. But, all of a sudden, I’m reconciled to who I am and where I am. … We take it day by day, and we’re doing OK.”
Some caregivers may lose patience with being asked the same question 10 times because their loved one with Alzheimer’s can’t remember the answer.
“You just need to take all that in your stride and recognize that this is a disease,” she said.
The Alzheimer’s Association has been “wonderful” help.
“I’ve made such lovely friends,” Jean said. “Something good comes out of everything, and that’s one of the good things that has happened.”
Staying connected is a boon for caregivers.
“When this is going on, you’ve lost your partner,” Jean said. “You don’t have a conversation. There’s not conversation at all.”
The disconnect is common with caregivers, and isolation can be a risk.
That’s why it’s important to maintain friendships and good family relationships, Jean said. “They really keep you bolstered.”
Beyond that, she recommends finding an activity you love to do and make enough time to do it. For example, she loves being outside, so she tends to flowers and a garden.
“I give almost all the vegetables away, and I just love doing that,” she said. “And that keeps me sane.”

Early onset

Lois knows the importance of a creative outlet.
She has to be doing something with her hands, she said. The day we visited, she showed us the bathroom she’d redone, including an old wooden baseball bat she repurposed as a towel rack.
Plus, she still maintains a business, Two Ladies with a Plan, with her best friend and fellow interior designer, Gayle Kauffman. Together, they refurbished Clarehouse, which provides quality end-of-life care and access to hospice services to people in need.
That’s not the only way Lois helps others, though. Before she was even diagnosed with Alzheimer’s, she responded to a newspaper advertisement John found about a drug trial for Alzheimer’s.
“I told them I’d do it for free,” Lois said, going along with the trial for 36 months until it was canceled. Currently, she’s on a new, 78-week drug trial.
In the meantime, she wants to see more support groups – and not just for caregivers.
“They have support for people like John, but what about me?” she wondered. Hopefully, one or two from his support group will bring spouses with early onset to the next meeting. Maybe that will start a new group.
Mostly, she’s not depressed, doesn’t get down, she said. But sometimes she asks, “Why me?”
Then, she started paraphrasing the Kris Krisstofferson song, “Why Me”:
“What have I ever done / to deserve even one of the blessings I’ve known,” she said.
Acknowledging those blessings is one of the reasons she does the drug trials, John said – to help others.
“If they can’t fix me, maybe they can fix the next person,” Lois said.


http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

Study hints at connection between cocoa and brain blood flow

Study hints at connection between cocoa and brain blood flow

http://consumer.healthday.com/senior-citizen-information-31/misc-aging-news-10/study-links-hot-cocoa-to-improved-brain-function-in-seniors-679021.html

As different areas of the brain need more energy to complete their tasks, they also need greater blood flow. A new study links drinking cocoa, which is high in antioxidants, to improved scores on a memory test in seniors with low levels of blood flow in their brains. In this small study, brain blood flow improved in the 18 participants whose brain blood flow levels were low. There was no effect among the others who had normal blood flow. The Alzheimer’s Association believes this very preliminary study is not well-designed as a test of an intervention and that no one should start drinking cocoa with the expectation that it will provide cognitive benefits.
Read the article >>

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

Distressed or Distressing: Re-Framing Behavior in Alzheimer’s

http://www.blogtalkradio.com/conversationsincare/2013/08/14/distressed-or-distressingre-framing-behavior-in-alzheimers

I wanted to share with you an episode of Conversations In Care that will be broadcasting Live tomorrow at 1:00pm Central time.
In this episode I will be joined by Eilon Caspi, Ph.D and dementia behavior specialist as we talk about re-framing behavior as a communication tool for the person with Alzheimer’s. We will discuss methods such as Validation Therapy and Need-Driven Dementia Compromised Behavior Model, and how these tools can be used to help prevent agitation and aggression.
Follow the link below to the live show, or if you can not listen in live the same link will take you to the archived show.
http://www.blogtalkradio.com/conversationsincare/2013/08/14/distressed-or-distressingre-framing-behavior-in-alzheimers
I have been honored to have this chosen as a Staff Pick by the Blog Talk Radio Team. I look forward to hearing how you enjoyed the information.
Thank you for joining in the Conversation.
Tami Neumann, CDP
Host of Conversations In Care
tami@conversations-in-care.com

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

You can drive the fight against Alzheimer’s

http://www.alz.org/join_the_cause_4772.asp?utm_source=DM&utm_medium=email&utm_campaign=email-all

That old vehicle in your garage can now get a second life and make a difference in the fight against Alzheimer’s disease. How? Consider donating your car for the cause!
It’s easy.
We accept cars, trucks, RVs and even boats! We take them whether they are in top shape or just a lump of metal. We’ll even pick up the vehicle from you at your convenience at no cost.
It’s fast.
Once you complete our simple Vehicle Donation Form, a towing service will call you within four business days to schedule a pick-up time.
It’s tax-deductible.
Your car donation is tax-deductible to the full extent of the law.
It feels good!
You don’t have to worry about dealers, ads or calling a tow truck. Your vehicle will help further our mission to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

If you have a vehicle that you are thinking of trading in or selling, consider donating it to the Alzheimer’s Association Donate a Car Program.

When your vehicle is sold, the proceeds will go to the Alzheimer’s Association to help fund research and enhance the lives of all those affected by the disease. You may also be able to deduct the fair market value of your vehicle as a charitable contribution for income tax purposes.

We have partnered with Car Program LLC, which accepts most vehicles, including cars, trucks, trailers, boats and RVs. The donation process is easy by phone.

Donate online:

Donate by phone:

  • If you have any questions, please call the Donate-A-Car processing center toll-free, seven days a week at 1.800.240.0160.

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/

Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023

Alzheimer’s disease therapeutics and diagnostics market will reach $8.3 billion in 2017

https://www.asdreports.com/shopexd.asp?id=72558&desc=titlelink&utm_source=ASDReports&utm_medium=email&utm_campaign=ASDR-72558&utm_content=homecare%40optimumseniorcare.com

A new report predicts the world market for Alzheimer’s disease therapeutics and diagnostics will reach $8.3bn in 2017. That revenue forecast and others appear in Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023, published in June 2013.

This report forecasts the Alzheimer’s disease (AD) therapeutics and diagnostics market will achieve strong revenue growth to 2023, especially beyond 2017. By 2017, some clinical trials will have finished and innovative products gained regulatory approval. The scope of the field is widening, with many organisations entering and collaborating.

Rodrigo Gutierrez Gamboa, a pharmaceutical industry analyst, said: “A high unmet need remains for innovative Alzheimer’s therapies that are able to alter the underlying course of this terminal disease. Several of the leading Alzheimer’s drugs have lost market exclusivity in important regions of the market, leaving the market exposed to intensified generic competition. There is also strong market need for diagnostic technologies for the early detection of AD.

“The R&D pipeline for Alzheimer’s therapies and diagnostics remains strong, with promising candidates, despite the series of high-profile failures in the late stages of clinical development. Beyond 2017, the market will be transformed by the introduction of disease-modifying therapies and innovative diagnostic technologies. The potential of new drugs and diagnostics in this market is enormous, given the high prevalence of AD and limited efficacy and utility of therapies and diagnostic tests currently available.”

This new report shows revenue forecasts to 2023 at overall world market, submarket, product and national level. Research, data and analyses cover activities of Pfizer, Eisai, Forest Laboratories, Lundbeck, Novartis and other pharmaceutical, biotechnology and diagnostics companies.

That study discusses R&D and predicts revenues to 2023 in leading national markets. The work analyses the US, Japan, Germany, France, the UK, Spain, Italy, India and China.

Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 therefore adds to our range of analytical reports on industries and markets in healthcare.

Report Details
Alzheimer’s medicine – your guide to technologies, trends and revenues
Where’s treatment of Alzheimer’s disease heading? This new report gives you revenue predictions for those drugs and diagnostic tests from 2013, helping you stay ahead.
There you find financial data, R&D trends, opportunities, and prospects. In particular, you see forecasted sales to 2023 at overall world market, submarket, product, and national level.
Read on, then, to explore that industry and see what its future market could be worth.
Forecasts to 2023 and other analyses to help you stay ahead
Besides revenue forecasting to 2023, you find historical data, growth rates, and market shares. You assess quantitative and qualitative analysis, business news, outlooks, and developments (R&D). You also gain 40 tables, 63 charts, and an interview.
Many opportunities exist for diagnosis and treatment of Alzheimer’s. Our study shows you the most promising and lucrative parts of that CNS market, helping you stay ahead. Now see how you can benefit your research, analyses and decisions, also saving time.
Finding data you need on that neurodegenerative disorder has just got easier. The following sections show how you benefit from our new analysis.
Discover outlooks for the world market and submarkets
Along with prediction of overall world market value to 2023, our report shows you revenue forecasting for main submarkets at world level:

  • Medicines for Alzheimer’s disease
  • Diagnostics for Alzheimer’s (including biomarkers).

Also our study discusses what stimulates and restrains that market. That analysis helps you identify potential and find ways for your business to develop. Assess brands too.
See forecasts for Alzheimer’s drugs
How will drugs perform to 2023 at world level? Our study predicts individual revenues of three products:

  • Namenda
  • Aricept
  • Exelon.

There you discover how high sales can go, to 2023. You see what’s happening, then, understanding trends, competition, challenges, and opportunities.
You find geographical revenue predictions too.
Discover prospects of national markets for those anti-dementia products
Developments worldwide expand the market for diagnosing, treating and monitoring neurodegenerative disorders. Developed and developing national markets hold high potential from 2013.
Our analyses show you individual revenue forecasts to 2023 for nine national markets and a regional block:

  • US
  • Japan
  • Germany, France, UK, Italy, and Spain (EU5)
  • Europe (grouped forecast)
  • India and China.

There you find potential. Large companies and specialty biopharma and diagnostics firms face many opportunities. Our study explains, assessing developments to help your work.
What affects producers of those diagnostic tests and medicines?
Our report discusses issues and events affecting that industry and market from 2013, including these:

  • Research and development (R&D) – drugs, diagnostic tests, and related technologies
  • Disease prevalence – expanding patient populations
  • Disease-modifying drugs and obstacles to cures
  • Regulatory guidelines – changes and opportunities.

The study also discusses other aspects of diagnosing and treating Alzheimer’s:

  • Needs for Alzheimer’s treatments
  • Drugs and related technologies to transform the market
  • Biomarkers and diagnostic imaging technologies, including structural, functional, and molecular imaging
  • Deep brain stimulation (functional neuromodulation)
  • Intellectual property (IP), licensing agreements and partnerships.

That way, you explore the industry’s strengths, weaknesses, opportunities, and threats. You also analyse it through Porter’s five forces.
See, then, what the future holds.
Prominent companies in that biomedical field and 2017 market value
Our new study predicts the world market for Alzheimer’s products will reach $8.3bn in 2017, and expand fast – especially from 2018.
Disease-modifying therapies will transform that market. New drugs hold great potential from 2018 to 2023, given the prevalence of Alzheimer’s and needs for more-effective treatments.
Our work thus shows you what technologies, products, and organisations hold greatest potential. In particular, the analysis investigates these companies:

  • Pfizer
  • Eisai
  • Forest Laboratories
  • Lundbeck
  • Novartis
  • TauRx Therapeutics
  • AC Immune.

There you assess results, product ranges, R&D pipelines, and outlooks.
Prospects for Alzheimer’s products and R&D are strong, and from 2013 there will arise many opportunities. Our work shows you the possibilities there, helping you stay ahead.
Eight ways Alzheimer’s Disease Therapeutics and Diagnostics: World Market 2013-2023 helps you
In particular, then, our investigation gives you the following knowledge:

  • Revenue to 2023 for the world market – discover that industry’s overall sales potential
  • Revenues to 2023 for world-level submarkets – investigate the potential of its components, finding the most promising places for investments and revenues
  • Revenues to 2023 for top products – find sales outlooks for top brands, seeing how they can compete and succeed
  • Forecasts to 2023 for national markets in North America, Europe, and Asia – discover the best countries for revenues and potential growth
  • Assessments of prominent companies – hear about developers and manufacturers’ activities, results, and outlooks
  • Review of R&D – explore progress in research and development, finding technological and medical possibilities for that neurological disorder
  • Competition and opportunities – investigate what shapes that market’s future, including ways to develop business
  • Analysis of what stimulates and restrains that industry and market – assess challenges and strengths, helping you compete and get advantages.

You gain information found nowhere else
That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.
With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
Assess progress and potential now, seeing what you can gain.
Discover predictions for Alzheimer’s-related products by ordering now
Our study lets you find data, trends, opportunities, and sales predictions for Alzheimer’s medicine. Avoid missing out – please order our new report now.

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/